Herein we established active HER2 targeting mPEGylated lecithin-stabilized micellar drug delivery system (HER2-LsbMDDs) loading with docetaxel (DTX), a first line chemotherapeutic agent for breast cancer (BC). Here, ERBB2 is linked to breast cancer.